Zhi Yang Ph.D Overview
- Company
- BioChain Institu...
- Primary Position
-
Co-Founder
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Zhi Yang Ph.D General Information
Biography
Dr. Zhi Yang is the Founder, Chairman and serves as a Managing Partner at BioVeda China Fund. He also is a Co-Founder of BioChain Institute. He serves as a Board Member at DiaCarta. He served as General Partner at BioVeda Capital. He has built portfolios of 25 companies, with 8 exits (4 IPO, 4 acquisitions). As an entrepreneur, he co-founded 7 companies, 6 of which continue to conduct business and grow. As a scientist, he was the principal inventor of more than 10 U.S. and international patents, which have been documented to have earned MNCs over $250 million. He was a senior fellow and faculty member at Rockefeller University and is now an advisor to the China Health and Medical Development Foundation, under China's Ministry of Health. He earned his Ph.D. in Molecular Biology and Biochemistry at Harvard University as a fellow of CUSBEA's first class, the first group of mainland Chinese biology scholars selected to be brought to the U.S. after China opened its doors in 1979.
Contact Information
Address
- 39600 Eureka Drive
- Newark, CA 94560
- United States
Zhi Yang Ph.D Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
BioChain Institute | Company | Co-Founder | Newark, CA | Diagnostic Equipment | |
BVCF | Investor | Founder, Chairman and Managing Partner | Shanghai, China | Venture Capital |
Zhi Yang Ph.D Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
BVCF | Shanghai, China | ||||
DiaCarta | Laboratory Services (Healthcare) | Privately Held (backing) | Venture Capital-Backed | Pleasanton, CA |
Zhi Yang Ph.D Lead Partner on Deals (11)
Zhi Yang Ph.D has been the lead partner on 11 deals. Their latest deal was with Cellenkos, a drug discovery company. The deal was made for on 04-Nov-2021.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Cellenkos | 04-Nov-2021 | Later Stage VC (Series A) | Completed | Drug Discovery | Houston, TX | |
Oculis Holding | 28-Apr-2021 | Completed | Drug Discovery | Zug, Switzerland | ||
DiaCarta | 09-Jan-2015 | Completed | Laboratory Services (Healthcare) | Pleasanton, CA | ||
CARsgen Therapeutics | 28-Nov-2014 | Completed | Biotechnology | Shanghai, China | ||
Jaguar Health | 07-May-2014 | Completed | Pharmaceuticals | San Francisco, CA | ||
Kunshan RiboQuark Pharmaceutical Technology | 07-Jan-2014 | Completed | Pharmaceuticals | Kunshan, China | ||
MicuRx Pharmaceuticals | 22-Aug-2013 | Completed | Pharmaceuticals | Shanghai, China | ||
Nexchem | 21-Apr-2011 | Completed | Drug Delivery | Jinhua, China | ||
Nexchem | 16-Dec-2009 | Buyout/LBO | Completed | Drug Delivery | Jinhua, China | |
NOD Pharmaceuticals | 30-Dec-2006 | Early Stage VC (Series B) | Completed | Biotechnology | San Diego, CA |
Zhi Yang Ph.D Network (85)
Board Members (11)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Folkert Kamphuis | Jaguar Health | Jaguar Health | San Francisco, CA | |
Jack Kaye | DiaCarta | Self | Pleasanton, CA | |
Nexchem | Nexchem | Jinhua, China | ||
Jaguar Health | Self | San Francisco, CA | ||
Jaguar Health | Self | San Francisco, CA |
Portfolio Executives (71)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Alick Sun | Cellenkos | Senior Vice President, Corporate & Business Development | 04-Nov-2021 | Houston, TX |
Simrit Parmar MD | Cellenkos | Founder, Chief Medical Officer & President | 04-Nov-2021 | Houston, TX |
Cellenkos | Chief Operating Officer | 04-Nov-2021 | Houston, TX | |
Cellenkos | Chief Operating Officer | 04-Nov-2021 | Houston, TX | |
Cellenkos | Chief Technology Officer & Advisor | 04-Nov-2021 | Houston, TX |
Fund Team Members (3)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Bing Zhuo | BVCF | BioVeda China Fund II | Shanghai, China |
Bing Zhuo | BVCF | Beijing Jinshuiquan RMB Fund | Shanghai, China |
BVCF | Shanghai, China | ||
BVCF | Shanghai, China | ||
BVCF | Shanghai, China |
Zhi Yang Ph.D Affiliated Funds (4)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
BioVeda China Fund IV | BVCF | Venture - General | Closed | 2018 | ||||
BioVeda China Fund II | BVCF | Venture - General | Closed | 2007 | ||||
BioVeda China Fund III | BVCF | Venture - General | Closed | 2012 | ||||
Beijing Jinshuiquan RMB Fund | BVCF | Venture - General | Closed | 2016 |
Zhi Yang Ph.D FAQs
-
Who is Zhi Yang Ph.D?
Dr. Zhi Yang is the Founder, Chairman and serves as a Managing Partner at BioVeda China Fund.
-
How much does Zhi Yang Ph.D typically invest?
Zhi Yang Ph.D's median deal size is
. -
What is Zhi Yang Ph.D’s main position?
Zhi Yang Ph.D’s primary position is Co-Founder.
-
What are the contact details for Zhi Yang Ph.D?
Zhi Yang Ph.D’s email address is zh
and his phone number is +1 (888) . -
How many active board seats does Zhi Yang Ph.D hold?
Zhi Yang Ph.D holds 2 board seats including BVCF and DiaCarta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »